Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages.

Nandi B, Shapiro M, Samur MK, Pai C, Frank NY, Yoon C, Prabhala RH, Munshi NC, Gold JS.

Oncoimmunology. 2016 May 24;5(8):e1189052. doi: 10.1080/2162402X.2016.1189052. eCollection 2016 Aug.

PMID:
27622061
2.

Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma.

Badawi MA, Abouelfadl DM, El-Sharkawy SL, El-Aal WE, Abbas NF.

Open Access Maced J Med Sci. 2015 Jun 15;3(2):209-14. doi: 10.3889/oamjms.2015.044. Epub 2015 Apr 27.

3.

Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1.

Wang H, Shao Q, Sun J, Ma C, Gao W, Wang Q, Zhao L, Qu X.

Oncoimmunology. 2016 Jan 4;5(4):e1122157. eCollection 2016 Apr.

PMID:
27141406
4.

Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.

Marech I, Ammendola M, Sacco R, Sammarco G, Zuccalà V, Zizzo N, Leporini C, Luposella M, Patruno R, Filippelli G, Russo E, Porcelli M, Gadaleta CD, De Sarro G, Ranieri G.

J Cell Mol Med. 2016 Jul;20(7):1373-80. doi: 10.1111/jcmm.12826. Epub 2016 Apr 22.

5.

Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer.

Chang PH, Pan YP, Fan CW, Tseng WK, Huang JS, Wu TH, Chou WC, Wang CH, Yeh KY.

Cancer Med. 2016 Mar;5(3):426-33. doi: 10.1002/cam4.602. Epub 2016 Jan 22.

6.

Prognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon Cancer.

Owusu BY, Vaid M, Kaler P, Klampfer L.

Biomark Cancer. 2015 Nov 2;7(Suppl 1):29-37. doi: 10.4137/BIC.S25247. eCollection 2015. Review.

7.

Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses.

Morris KT, Castillo EF, Ray AL, Weston LL, Nofchissey RA, Hanson JA, Samedi VG, Pinchuk IV, Hudson LG, Beswick EJ.

Oncotarget. 2015 Sep 8;6(26):22338-47.

8.

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S.

Semin Cancer Biol. 2015 Dec;35 Suppl:S25-54. doi: 10.1016/j.semcancer.2015.02.006. Epub 2015 Apr 17. Review.

9.

Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway.

Giakoustidis A, Mudan S, Hagemann T.

Cancer Microenviron. 2015 Dec;8(3):177-86. doi: 10.1007/s12307-014-0155-5. Epub 2014 Oct 3.

10.

Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner.

Xu H, Lai W, Zhang Y, Liu L, Luo X, Zeng Y, Wu H, Lan Q, Chu Z.

BMC Cancer. 2014 May 10;14:330. doi: 10.1186/1471-2407-14-330.

11.

Exercise effects on polyp burden and immune markers in the ApcMin/+ mouse model of intestinal tumorigenesis.

McClellan JL, Steiner JL, Day SD, Enos RT, Davis MJ, Singh UP, Murphy EA.

Int J Oncol. 2014 Aug;45(2):861-8. doi: 10.3892/ijo.2014.2457. Epub 2014 May 22.

12.

Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis.

Pancione M, Giordano G, Remo A, Febbraro A, Sabatino L, Manfrin E, Ceccarelli M, Colantuoni V.

J Immunol Res. 2014;2014:686879. doi: 10.1155/2014/686879. Epub 2014 Jan 16. Review.

13.

Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2.

Engström A, Erlandsson A, Delbro D, Wijkander J.

Int J Oncol. 2014 Feb;44(2):385-92. doi: 10.3892/ijo.2013.2203. Epub 2013 Dec 2.

14.

A New Herbal Formula, KSG-002, Suppresses Breast Cancer Growth and Metastasis by Targeting NF- κ B-Dependent TNF α Production in Macrophages.

Woo SM, Choi YK, Cho SG, Park S, Ko SG.

Evid Based Complement Alternat Med. 2013;2013:728258. doi: 10.1155/2013/728258. Epub 2013 May 30.

15.

Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer.

Day SD, Enos RT, McClellan JL, Steiner JL, Velázquez KT, Murphy EA.

Cytokine. 2013 Oct;64(1):454-62. doi: 10.1016/j.cyto.2013.04.031. Epub 2013 Jun 2.

16.

IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.

Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J.

Mol Cancer. 2012 Nov 23;11:87. doi: 10.1186/1476-4598-11-87.

17.

Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.

McClellan JL, Davis JM, Steiner JL, Enos RT, Jung SH, Carson JA, Pena MM, Carnevale KA, Berger FG, Murphy EA.

Am J Physiol Gastrointest Liver Physiol. 2012 Nov 15;303(10):G1087-95. doi: 10.1152/ajpgi.00252.2012. Epub 2012 Sep 27.

18.

M2-polarized macrophages promote metastatic behavior of Lewis lung carcinoma cells by inducing vascular endothelial growth factor-C expression.

Zhang B, Zhang Y, Yao G, Gao J, Yang B, Zhao Y, Rao Z, Gao J.

Clinics (Sao Paulo). 2012 Aug;67(8):901-6.

19.

Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Erreni M, Mantovani A, Allavena P.

Cancer Microenviron. 2011 Aug;4(2):141-54. doi: 10.1007/s12307-010-0052-5. Epub 2010 Sep 17.

20.

The colorectal tumor microenvironment: the next decade.

Beauchemin N.

Cancer Microenviron. 2011 Aug;4(2):181-5. doi: 10.1007/s12307-011-0074-7. Epub 2011 Jul 7.

Items per page

Supplemental Content

Write to the Help Desk